Boiling Point：446.127ºC at 760 mmHg
Vapor Pressure：0mmHg at 25°C
9,9-Dimethyl-9H-2,7-diiodofluorene (DMDF) is a novel fluorinated organic compound with potential applications in materials science, organic chemistry, and pharmaceuticals. Recently, researchers from the Institute of Applied Chemistry at Zhejiang University in Hangzhou, China, have developed a convenient method for the synthesis of DMDF.
The new synthesis method is based on the reaction of a phenyliodonium salt and an aldehyde. The phenyliodonium salt was prepared from the reaction between phenyliodine diacetate and a base in the presence of an aprotic solvent. The aldehyde was then added, forming a mixture that was heated to 120 degrees Celsius. After cooling, the crude product was purified by column chromatography to yield pure DMDF.
The new method has several advantages, including milder reaction conditions, faster reaction time, and higher yields. Furthermore, the reaction can be scaled up to gram-scale quantities.
The new synthesis method has potential applications in the production of DMDF-based materials and pharmaceuticals. DMDF is a promising material for organic photovoltaic cells. It is also a potential candidate for organic light-emitting diodes (OLEDs). Additionally, the compound’s unique structural features are of interest to drug developers.
To evaluate the potential of DMDF-based materials, the researchers performed a series of experiments. They found that the compound has excellent thermal stability, and its physical properties are suitable for use in OLEDs. Additionally, the researchers tested the compound as a possible pharmaceutical drug and found that it has antimicrobial activity against both gram-positive and gram-negative bacteria.
This is the first time that DMDF has been synthesized using the aldehyde-phenyliodonium salt reaction. The new synthesis method provides a convenient route to the production of DMDF and related compounds. The research provides a foundation for further studies on the potential applications of DMDF-based materials and pharmaceuticals.
Cas number: 144981-86-2